What is Beta Bionics, Inc. Common Stock's Market Cap?

Beta Bionics, Inc. Common Stock's Market Cap is $869.7M, based on as-reported figures from SEC (XBRL) filings.

What is Beta Bionics, Inc. Common Stock's Enterprise Value?

Beta Bionics, Inc. Common Stock's Enterprise Value is $689.3M, based on as-reported figures from SEC (XBRL) filings.

What is Beta Bionics, Inc. Common Stock's Price / Sales?

Beta Bionics, Inc. Common Stock's Price / Sales is 7.3×, based on as-reported figures from SEC (XBRL) filings.

What is Beta Bionics, Inc. Common Stock's EV / Revenue?

Beta Bionics, Inc. Common Stock's EV / Revenue is 5.8×, based on as-reported figures from SEC (XBRL) filings.

What is Beta Bionics, Inc. Common Stock's EV / EBITDA?

Beta Bionics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Beta Bionics, Inc. Common Stock's Revenue (TTM)?

Beta Bionics, Inc. Common Stock's Revenue (TTM) is $119.0M, based on as-reported figures from SEC (XBRL) filings.

What is Beta Bionics, Inc. Common Stock's Net Income (TTM)?

Beta Bionics, Inc. Common Stock's Net Income (TTM) is -$73.0M, based on as-reported figures from SEC (XBRL) filings.

What is Beta Bionics, Inc. Common Stock's EBITDA?

Beta Bionics, Inc. Common Stock's EBITDA is -$80.8M, based on as-reported figures from SEC (XBRL) filings.

What is Beta Bionics, Inc. Common Stock's Diluted EPS (TTM)?

Beta Bionics, Inc. Common Stock's Diluted EPS (TTM) is -1.62, based on as-reported figures from SEC (XBRL) filings.

What is Beta Bionics, Inc. Common Stock's EBITDA Margin?

Beta Bionics, Inc. Common Stock's EBITDA Margin is -67.9%, based on as-reported figures from SEC (XBRL) filings.

Beta Bionics, Inc. Common Stock (BBNX) Financial Statements

Beta Bionics, Inc. Common Stock

SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

FIGI BBG00JNGG9R1

XNAS · usd

19.33▼ 0.09 (-0.46%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close19.42

Day's Range18.75 – 19.52

52-Week Range8.80 – 32.71

Volume900.5K

Avg Volume1.3M

Share Statistics

Shares Outstanding

Employees423

ExchangeXNAS

Listed2025-01-30

Share count as of July 27, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Beta Bionics, Inc. Common Stock (BBNX)

What is Beta Bionics, Inc. Common Stock's Market Cap?: Beta Bionics, Inc. Common Stock's Market Cap is $869.7M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Enterprise Value?: Beta Bionics, Inc. Common Stock's Enterprise Value is $689.3M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Price / Sales?: Beta Bionics, Inc. Common Stock's Price / Sales is 7.3×, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's EV / Revenue?: Beta Bionics, Inc. Common Stock's EV / Revenue is 5.8×, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's EV / EBITDA?: Beta Bionics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Revenue (TTM)?: Beta Bionics, Inc. Common Stock's Revenue (TTM) is $119.0M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Net Income (TTM)?: Beta Bionics, Inc. Common Stock's Net Income (TTM) is -$73.0M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's EBITDA?: Beta Bionics, Inc. Common Stock's EBITDA is -$80.8M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Diluted EPS (TTM)?: Beta Bionics, Inc. Common Stock's Diluted EPS (TTM) is -1.62, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's EBITDA Margin?: Beta Bionics, Inc. Common Stock's EBITDA Margin is -67.9%, based on as-reported figures from SEC (XBRL) filings.